CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Dipharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALNov 9, 2022
Treatment Of Phenylketonuria With Bh4BIOMARIN PHARMACEUTICALOct 26, 2022
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALJul 13, 2021
New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)PiperazineLEK PHARMACEUTICALS DDDec 5, 2019

Explore Dipharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 29, 2021Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant Drug1

Top competitors of Dipharma

List of top competitors of Dipharma based on patent oppositions.